Home・Aktien・Aurinia Pharmaceuticals Inc

Search

Aurinia Pharmaceuticals Inc

Open

BrancheGesundheitswesen

14.93 2.47

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

14.47

Max

14.8

Schlüsselkennzahlen
By Trading Economics
Einkommen	-176M 34M
Verkäufe	591K 78M
KGV Branchendurchschnitt	7.112 64.641
EPS	0.25
Gewinnspanne	44.212
Angestellte	128
EBITDA	2.7M 50M

Empfehlungen
By TipRanks
Empfehlungen	Buy
12-Monats-Prognose	+7.55% upside

Dividenden
By Acuity
Nächstes Ergebnis	6. Aug. 2026

Marktstatistiken
By TradingEconomics
Marktkapitalisierung	-92M 2B
Vorheriger Eröffnungskurs	12.46
Vorheriger Schlusskurs	14.93

Nachrichtenstimmung

By Acuity

50%

50%

151 / 340 Ranking in Healthcare

Aurinia Pharmaceuticals Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

3. Aug. 2026, 22:01 UTC

Aurinia Pharmaceuticals shares are higher in after-market hours, despite being below the 20-day moving average and three prior lower daily closes.

1. Aug. 2026, 00:01 UTC

Aurinia Pharmaceuticals Inc is trading lower in after-market hours, reflecting a significant decline in the overall market and ongoing weakness in performance metrics.

31. Juli 2026, 21:01 UTC

Aurinia Pharmaceuticals Inc is higher in after-market trading, rising notably from a flat start. The stock remains below its 20-day moving average.

30. Juli 2026, 20:31 UTC

Aurinia Pharmaceuticals Inc. shares rose in after-market trading, following a broader market trend as the S&P 500 also gained. No specific news was identified.

29. Juli 2026, 22:01 UTC

Aurinia Pharmaceuticals Inc shares are lower in after-market hours, showing notable weakness and trading below its 20-day moving average. No specific news was identified.

28. Juli 2026, 19:36 UTC

Aurinia Pharmaceuticals shares are lower, reflecting volatility amid broader market conditions. The stock is trading significantly below its 20-day moving average.

27. Juli 2026, 19:16 UTC

Aurinia Pharmaceuticals is trading higher, benefiting from lower oil prices and easing inflation concerns ahead of the Federal Reserve meeting later this week.

24. Juli 2026, 18:26 UTC

Aurinia Pharmaceuticals is trading higher, despite pulling back from earlier gains. Broader market volatility, influenced by declining oil prices, impacts sentiment.

22. Juli 2026, 19:46 UTC

Aurinia Pharmaceuticals shares are lower today, continuing a decline since Tuesday's close. The stock is near its one-month trading range's lower end.

21. Juli 2026, 19:16 UTC

Aurinia Pharmaceuticals is higher today, supported by a broader market uptick as investor interest in AI-related stocks grows ahead of major tech earnings.

20. Juli 2026, 20:01 UTC

Aurinia Pharmaceuticals is lower today, reflecting broader market declines amid geopolitical tensions and oil price fluctuations. The stock hit a session low earlier.

Peer-Vergleich

Kursveränderung

Aurinia Pharmaceuticals Inc Prognose

Kursziel

By TipRanks

7.55% Vorteil

12-Monats-Prognose

Durchschnitt 15.67 USD 7.55%

Hoch 17 USD

Tief 15 USD

Basierend auf 3 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Aurinia Pharmaceuticals Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Buy

3 ratings

1

Buy

2

Halten

0

Sell

Basierend auf 3 Analysten, die in den letzten 3 Monaten Aktienbewertungen für Aurinia Pharmaceuticals Inc – Dist abgegeben haben.

Stimmung

By Acuity

151 / 340 Ranking in Gesundheitswesen

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States. It offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd. The company was incorporated in 1993 and is headquartered in Edmonton, Canada.

Andere Aktien aus dem Sektor

JNJ

Johnson and Johnson

254.99

UNH

UnitedHealth Group Inc

407.89

NVS

Novartis AG

153.02

AZN

AstraZeneca PLC

155.34

TMO

Thermo Fisher Scientific Inc

564.36

Live chat